Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-15

Clinical Trial Update: Study of the Efficacy and Safety of Bupivacaine TTS Patch in Patients With Chronic Low Back Pain [Phase 2]

View source ↗

Summary

Phase 2 trial update for a bupivacaine transdermal patch in chronic low back pain assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine TTS Patch (bupivacaine transdermal patch)

Snippet

Sponsor: Durect | Conditions: Chronic Low Back Pain | Phase 2 | Status: COMPLETED